- Abstract:
-
In experimental transplantation, blockade of CD40-CD40 ligand (CD40L) interactions has proved effective at permitting long-term graft survival and has recently been approved for clinical evaluation. We show that CD4+ T cell-mediated rejection is prevented by anti-CD40L mAb therapy but that CD8+ T cells remain fully functional. Furthermore, blocking CD40L interactions has no effect on CD8+ T cell activation, proliferation, differentiation, homing to the target allograft, or cytokine production...
Expand abstract - Publication status:
- Published
- Journal:
- Journal of immunology (Baltimore, Md. : 1950)
- Volume:
- 165
- Issue:
- 2
- Pages:
- 1111-1118
- Publication date:
- 2000-07-05
- DOI:
- EISSN:
-
1550-6606
- ISSN:
-
0022-1767
- URN:
-
uuid:6f919ebb-ec70-42a4-85ed-2f77ad032522
- Source identifiers:
-
135918
- Local pid:
- pubs:135918
- Language:
- English
- Keywords:
- Copyright date:
- 2000
Journal article
CD40-CD40 ligand-independent activation of CD8+ T cells can trigger allograft rejection.
Actions
Authors
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record